Abstract: Methods for prolongation of climax time in a patient in need thereof are presented, as are methods for treating premature ejaculation by local administration of a Clostridial neurotoxin, such a botulinum neurotoxin, to the patient, are provided.
Type:
Grant
Filed:
February 22, 2012
Date of Patent:
December 11, 2012
Assignee:
Allergan, Inc.
Inventors:
Gustavo M. Gaxiola, Ivan E. Aguilar, Gilberto P. Paz
Abstract: Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
Type:
Grant
Filed:
May 10, 2012
Date of Patent:
December 4, 2012
Assignee:
Allergan, Inc.
Inventors:
Jennifer L. Ton, Hemant A. Patel, Ronald C. Bates, Wajdie M. Ahmad
Abstract: A high potency botulinum toxin pharmaceutical composition comprising two excipients (such as albumin and sodium chloride) in a weight to weight ratio of between about 1 and about 100.
Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of botulinum toxin types A, B, C, D, E, F and G.
Type:
Grant
Filed:
December 2, 2003
Date of Patent:
May 29, 2012
Assignee:
Allergan, Inc.
Inventors:
Kei Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
Abstract: The present invention provides a method for treating proliferative skin diseases comprising the administration of an effective amount of tazarotene and an effective amount of a corticosteroid. This invention is especially useful for treating psoriasis.